StockData
Alpha Teknova, Inc. logo

Alpha Teknova, Inc. (TKNO) stock

TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30150% above fair value
$8.29−0.32 (-3.77%)

Close on Nov 12, 2026Market cap $445.34MP/E –Yield –

Alpha Teknova, Inc. grew revenue 15.4% to $45.95M over the twelve months to Sep 30, 2026. Free cash flow was -$6.38M. At the latest close the market valued the company at $445.34M.

Revenue
$45.95M
+15.4% vs. a year earlier
Operating income
-$15.00M
TTM Q3 2026
Free cash flow
-$6.38M
TTM Q3 2026
EPS, diluted
-$0.29
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$445.34M
P/E ratio
–
Price to sales
9.69
Price to book
7.45
Dividend yield
–
Free cash flow yield
-1.43%

Fundamentals

Revenue
$45.95M
Net income
-$15.97M
EPS, diluted
-$0.29
Free cash flow
-$6.38M
Book value per share
$1.11
Diluted shares
54M

Trading

Next earnings
Feb 25, 2027 (estimated, during market hours)
Previous close
$8.62
Open
$8.41
Day's range
$8.04 – $8.64
Volume
380,447
Average volume (20 days)
839,625
Index membership
Russell 2000 (since Jun 2025)
Beta (5 years)
1.18
52-week range
$1.91 – $9.48
RSI (14 days)
55.5
Volatility (1 year)
80.8%
Relative volume
1.04×
WACC
10.8%

Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2021, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodTKNOS&P 500DifferenceTKNO per yearS&P 500 per year
1 month-4.7%-2.7%−2.0 pts
3 months+12.2%-1.7%+14.0 pts
Year to date+118.3%+11.9%+106.4 pts
1 year+86.0%+12.0%+74.0 pts
3 years+325.4%+78.2%+247.2 pts+62.0%+21.2%
5 years-68.6%+73.2%−141.8 pts-20.7%+11.6%

Seven years at a glance

Fiscal years 2019 to 2025 and trailing twelve months, USD

Revenue

$45.95M+15.4% YoY

Gross profit

$16.74M+35.8% YoY

Operating income

-$15.00M

Net income

-$15.97M

EPS, diluted

-$0.29

Free cash flow

-$6.38M
Reported periodTrailing twelve months

Press releases

Releases Alpha Teknova filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Alpha Teknova

In Vitro & In Vivo Diagnostic Substances

Alpha Teknova, Inc. produces critical reagents used in the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company provides custom and catalog chemical formulations through two primary product categories: Lab Essentials and Clinical Solutions. Its product offerings include pre-poured media plates for cell cultivation, liquid microbial culture media and supplements for cellular expansion, and molecular biology reagents for sample processing and purification. Its customers encompass pharmaceutical and biotechnology firms, contract development and manufacturing organizations, in vitro diagnostics entities, and academic and government research institutions.

Company profile, executives and history

Alpha Teknova stock: common questions

What is Alpha Teknova's stock price?

TKNO closed at $8.29 on Nov 12, 2026, down 3.77% on the day. Over the past 52 weeks it traded between $1.91 and $9.48.

What is Alpha Teknova's market cap?

Alpha Teknova was worth $445.34M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

What is TKNO's P/E ratio?

Alpha Teknova lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.29), so it has no meaningful P/E ratio.

How much revenue does Alpha Teknova make?

Alpha Teknova reported revenue of $45.95M for the twelve months to Sep 30, 2026, up 15.4% from a year earlier.

Does Alpha Teknova pay a dividend?

No. Alpha Teknova has not paid a cash dividend over the last twelve months.

When does Alpha Teknova report earnings next?

Alpha Teknova is expected to report Q4 FY2026 results on Feb 25, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.

How has TKNO stock performed over the past year?

Including dividends, TKNO returned +86.0% over the past year, against +12.0% for the S&P 500.

How many TKNO shares are sold short?

2M shares were sold short at the latest FINRA report, 2.91% of the float, or 1.4 days of average trading volume.

Who are Alpha Teknova's competitors?

Companies most similar to Alpha Teknova by business, industry and size include TRIB, ICCC, NTLA, NNNN, AQST.

See a number that looks wrong?